Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Baoyuan Biopharmaceuticals Technology (Hangzhou) Co., Ltd.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.
- Drug Delivery
- Other Names / Subsidiaries
- AnHeart Therapeutics, Co., Ltd